Literature DB >> 8342829

False-negative results with muscle caffeine halothane contracture testing for malignant hyperthermia.

H Isaacs1, M Badenhorst.   

Abstract

BACKGROUND: During the period 1985-1991, 350 muscle contracture studies have been performed in the authors' laboratory, and during this period, they became aware of an occasional false-negative result. The findings pertaining to the four cases so classified are presented in detail.
METHODS: In 1985 the protocol for the muscle strip caffeine halothane testing procedure adopted was that of the European Malignant Hyperthermia Society.
RESULTS: Thirty-six percent of the cases tested susceptible for malignant hyperthermia, 15% tested equivocal in that they responded either to halothane or to caffeine singularly, and 49% gave a normal response. In this latter group, the authors believe they identified four false-negative results.
CONCLUSIONS: This study documents the rarity of false-negative results and substantiates the reliability of caffeine halothane testing as a biologic test in diagnosing the presence of a potentially serious problem.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8342829     DOI: 10.1097/00000542-199307000-00003

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  7 in total

1.  Cardiac arrest and rhabdomyolysis after succinylcholine in a healthy child.

Authors:  S Kiyama; T Yoshikawa; Y Kobayashi
Journal:  J Anesth       Date:  1995-12       Impact factor: 2.078

Review 2.  [Malignant hyperthermia].

Authors:  T Metterlein; F Schuster; B M Graf; M Anetseder
Journal:  Anaesthesist       Date:  2014-12       Impact factor: 1.041

3.  JSA guideline for the management of malignant hyperthermia crisis 2016.

Authors: 
Journal:  J Anesth       Date:  2017-02-28       Impact factor: 2.078

Review 4.  Malignant hyperthermia.

Authors:  R Ben Abraham; P Adnet; V Glauber; A Perel
Journal:  Postgrad Med J       Date:  1998-01       Impact factor: 2.401

5.  A multi-dimensional analysis of genotype-phenotype discordance in malignant hyperthermia susceptibility.

Authors:  Carlos A Ibarra Moreno; Natalia Kraeva; Elena Zvaritch; Lourdes Figueroa; Eduardo Rios; Leslie Biesecker; Filip Van Petegem; Philip M Hopkins; Sheila Riazi
Journal:  Br J Anaesth       Date:  2020-08-27       Impact factor: 9.166

6.  Diagnosis of malignant hyperthermia: a comparison of the in vitro contracture test with the molecular genetic diagnosis in a large pedigree.

Authors:  J M Healy; K A Quane; K E Keating; M Lehane; J J Heffron; T V McCarthy
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

7.  Intra-operative post-induction hyperthermia, possibly malignant hyperthermia: Anesthetic implications, challenges and management.

Authors:  Michell Gulabani; Pavan Gurha; Sabih Ahmad; Prashant Dass
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.